Article 7 - MEDICAL USES OF RADIOACTIVE MATERIAL
- Section R9-7-701 - License Required
- Section R9-7-702 - Definitions.
- Section R9-7-703 - License for Medical Use of Radioactive Material
- Section R9-7-704 - Provisions for the Protection of Human Research Subjects
- Section R9-7-705 - Authority and Responsibilities for the Radiation Protection Program
- Section R9-7-706 - Supervision
- Section R9-7-707 - Written Directives
- Section R9-7-708 - Procedures for Administrations Requiring a Written Directive
- Section R9-7-709 - Sealed Sources or Devices for Medical Use
- Section R9-7-710 - Radiation Safety Officer and Associate Radiation Safety Officer Training
- Section R9-7-711 - Authorized Medical Physicist Training
- Section R9-7-712 - Authorized Nuclear Pharmacist Training
- Section R9-7-713 - Determination of Prescribed Dosages, and Possession, Use, and Calibration of Instruments
- Section R9-7-714 - Authorization for Calibration, Transmission, and Reference Sources
- Section R9-7-715 - Requirements for Possession of Sealed Sources and Brachytherapy Sources
- Section R9-7-716 - Surveys of Ambient Radiation Exposure Rate, Surveys for Contamination, and PET Radiation Exposure Concerns
- Section R9-7-717 - Release of Individuals Containing Radioactive Material or Implants Containing Radioactive Material
- Section R9-7-718 - Mobile Medical Service
- Section R9-7-719 - Training for Uptake, Dilution, and Excretion Studies
- Section R9-7-720 - Permissible Molybdenum-99, Strontium-82, and Strontium-85 Concentrations
- Section R9-7-721 - Training for Imaging and Localization Studies Not Requiring a Written Directive
- Section R9-7-722 - Safety Instruction and Precautions for Use of Unsealed Radioactive Material Requiring a Written Directive
- Section R9-7-723 - Training for Use of Unsealed Radioactive Material Requiring a Written Directive, Including Treatment of Hyperthyroidism, and Treatment of Thyroid Carcinoma
- Section R9-7-724 - Surveys after Brachytherapy Source Implant and Removal; Accountability
- Section R9-7-725 - Safety Instructions and Precautions for Brachytherapy Patients that Cannot be Released Under R9-7- 717
- Section R9-7-726 - Calibration Measurements of Brachytherapy Sources, Decay of Sources Used for Ophthalmic Treatments, and Computerized Treatment Planning Systems
- Section R9-7-727 - Training for Use of Manual Brachytherapy Sources and Training for the Use of Strontium-90 Sources for Treatment of Ophthalmic Disease
- Section R9-7-728 - Training for Use of Sealed Sources for Diagnosis
- Section R9-7-729 - Surveys of Patients and Human Research Subjects Treated with a Remote Afterloader Unit
- Section R9-7-730 - Installation, Maintenance, Adjustment, and Repair of an Afterloader Unit, Teletherapy Unit, or Gamma Stereotactic Radiosurgery Unit
- Section R9-7-731 - Safety Procedures and Instructions for Remote Afterloader Units, Teletherapy Units, and Gamma Stereotactic Radiosurgery Units
- Section R9-7-732 - Safety Precautions for Remote Afterloader Units, Teletherapy Units, and Gamma Stereotactic Radiosurgery Units
- Section R9-7-733 - Dosimetry Equipment
- Section R9-7-734 - Full Calibration Measurements on Teletherapy Units
- Section R9-7-735 - Full Calibration Measurements on Remote After-loader Units
- Section R9-7-736 - Full Calibration Measurements on Gamma Stereotactic Radiosurgery Units
- Section R9-7-737 - Periodic Spot-checks for Teletherapy Units
- Section R9-7-738 - Periodic Spot-checks for Remote Afterloader Units
- Section R9-7-739 - Periodic Spot-checks for Gamma Stereotactic Radiosurgery Units
- Section R9-7-740 - Additional Requirements for Mobile Remote Afterloader Units
- Section R9-7-741 - Additional Radiation Surveys of Sealed Sources used in Radiation Therapy
- Section R9-7-742 - Five-year Inspection for Teletherapy and Gamma Stereotactic Radiosurgery Units
- Section R9-7-743 - Therapy-related Computer Systems
- Section R9-7-744 - Training for Use of Remote Afterloader Units, Teletherapy Units, and Gamma Stereotactic Radiosurgery Units
- Section R9-7-745 - Report and Notification of a Medical Event
- Section R9-7-746 - Report and Notification of a Dose to an Embryo, Fetus, or Nursing Child
- Exhibit A - Medical Use Groups